Completed PHASE4 INTERVENTIONAL 2-arm NCT01261637

Abdominal Wall Local Anesthesia to Maximize Postoperative Pain Control After Cesarean Delivery

Ultrasound Guided 0.25% Ropivacaine Transversus Abdominis Plane Block in Addition to Intrathecal Morphine and Multimodal Analgesia for the Management of Postoperative Pain Among Women Undergoing Cesarean Delivery.

Sponsor: IWK Health Centre

Conditions Postoperative Pain

Interventions Ropivicaine Saline placebo

Updated 5 times since 2017 Last updated: May 22, 2013 Started: Jul 31, 2009 Primary completion: Jul 31, 2010 Completion: Jan 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01261637, this PHASE4 trial focuses on Postoperative Pain and remains completed. Sponsored by IWK Health Centre, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jul 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

IWK Health Centre

Data source: IWK Health Centre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Halifax, Canada